ADAM10 and fragile X syndrome: Increased levels of sAPPα and ADAM10 were observed only in FXS individuals belonging to groups 1 and 2 (<30 years) (Figure 1A,B) compared to age-matched controls, whereas no significant differences were detected in group 3 (>30 years) (Figure 1C).